TY - JOUR
T1 - Chemical and Enzymatic Site Specific PEGylation of hGH
T2 - The Stability and in vivo Activity of PEG-N-Terminal-hGH and PEG-Gln141-hGH Conjugates
AU - Grigoletto, Antonella
AU - Mero, Anna
AU - Zanusso, Ilenia
AU - Schiavon, Oddone
AU - Pasut, Gianfranco
PY - 2016/1/1
Y1 - 2016/1/1
N2 - The use of therapeutic proteins is often impaired by their short in vivo half-lives. PEGylation has been exploited to enhance protein stability and to prolong the pharmacokinetic. The biophysical characterization of two site-specific mono-PEGylated forms of human growth hormone (hGH) - chemically N-terminal PEGylated hGH (PEG-Nter-hGH) and enzymatically Gln141 PEGylated hGH (PEG-Gln141-hGH) via transglutaminase - is outlined here and their pharmacodynamics are compared. The thermal stability of PEG-Nter-hGH was increased with respect to that of hGH and PEG-Gln141-hGH. Pharmacodynamic studies in rats showed that a single injection of the conjugates had a better or comparable potency with respect to a daily hGH on a week schedule in terms of weight gain, femoral length, and tibial diaphysis width. Two different site-specific monoPEGylated forms of hGH are prepared using a chemical, N-terminal PEGylation and enzymatic, transglutaminase-based conjugation approaches. The N-terminal PEGylation yielded a conjugate with a higher thermal stability and, of particular interest, one that is able to recover the secondary structure after thermal denaturation.
AB - The use of therapeutic proteins is often impaired by their short in vivo half-lives. PEGylation has been exploited to enhance protein stability and to prolong the pharmacokinetic. The biophysical characterization of two site-specific mono-PEGylated forms of human growth hormone (hGH) - chemically N-terminal PEGylated hGH (PEG-Nter-hGH) and enzymatically Gln141 PEGylated hGH (PEG-Gln141-hGH) via transglutaminase - is outlined here and their pharmacodynamics are compared. The thermal stability of PEG-Nter-hGH was increased with respect to that of hGH and PEG-Gln141-hGH. Pharmacodynamic studies in rats showed that a single injection of the conjugates had a better or comparable potency with respect to a daily hGH on a week schedule in terms of weight gain, femoral length, and tibial diaphysis width. Two different site-specific monoPEGylated forms of hGH are prepared using a chemical, N-terminal PEGylation and enzymatic, transglutaminase-based conjugation approaches. The N-terminal PEGylation yielded a conjugate with a higher thermal stability and, of particular interest, one that is able to recover the secondary structure after thermal denaturation.
KW - enzymatic PEGylation
KW - hGH
KW - PEGylation
KW - transglutaminase
UR - http://www.scopus.com/inward/record.url?scp=84954376903&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84954376903&partnerID=8YFLogxK
U2 - 10.1002/mabi.201500282
DO - 10.1002/mabi.201500282
M3 - Article
AN - SCOPUS:84954376903
VL - 16
SP - 50
EP - 56
JO - Macromolecular Bioscience
JF - Macromolecular Bioscience
SN - 1616-5187
IS - 1
ER -